|
DE102019122497A1
|
|
Adenosine A2B receptor agonist, used to treat diseases of the musculoskeletal system
|
|
WO2020011945A1
|
|
Floating gastric retentive drug delivery system
|
|
EP3757209A1
|
|
Enzymatic production of levan-based, prebiotic fructooligosaccharides
|
|
WO2019186514A2
|
|
Aptamers for targeted activaton of t cell-mediated immunity
|
|
EP3683310A1
|
|
Aptamer and use of the aptamer in the diagnosis and treatment of cancer
|
|
DE102018131820A1
|
|
Device and method for maintaining polarization in highly birefringent fibers under the influence of environmental disturbances
|
|
DE102018120092A1
|
|
Process for tillage and / or soil modification by introducing growth-promoting organic material into a field soil
|
|
EP3604554A1
|
|
A method of identifying or producing an aptamer for a denatured peptide or protein
|
|
DE102018118139A1
|
|
Device and method for picking up oil from a water surface
|
|
EP3599285A1
|
|
Method of diagnosing asthma subtypes
|
|
EP3587382A1
|
|
Click-mass spectrometry of alkyne-labeled compounds
|
|
DE102017131083A1
|
|
System and method for recording and visualizing a 3D scene in real time
|
|
EP3498282A1
|
|
6'-sialyllactose for use in the treatment of hearing loss
|
|
DE102017128269A1
|
|
Measuring cell for the determination of diffusion coefficients and solubilities of gases
|
|
EP3438250A1
|
|
Cell derived extracellular vesicles for the treatment of diseases
|
|
EP3382034A1
|
|
Gene expression analysis by means of generating a circularized single stranded cdna library
|
|
EP3360549A1
|
|
Small molecule therapeutics for treating metachromatic leukodystrophy
|
|
EP3357489A1
|
|
Mutated arylsulfatase a
|
|
CN108472694A
|
|
The network retained for stabilizing gas under liquid
|
|
HK1225755A1
|
|
5' triphosphate oligonucleotide with blunt end and uses thereof
|
